Prevalence of IgA-antiendomysial antibody in asymptomatic low bone mineral density

American Journal of Gastroenterology

Volumn 96, Issue 1, 2001, Pages 120-125

  Mather, Kieren J ^a   Meddings, Jon B ^a   Beck, Paul L ^a   Scott, R Brent ^a   Hanley, David A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOMYSIUM ANTIBODY; IMMUNOGLOBULIN A ANTIBODY;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CELIAC DISEASE; FEMALE; FEMUR NECK; FRACTURE; GASTROINTESTINAL DISEASE; HUMAN; INTESTINE BIOPSY; INTESTINE MUCOSA PERMEABILITY; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERODIAGNOSIS; WRIST;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; BONE DENSITY; CELIAC DISEASE; COMORBIDITY; CONFIDENCE INTERVALS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; PROBABILITY; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 0035138849     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02254-1     Document Type: Article

References (35)

1. Epidemiology of celiac sprue: A community-based study
2. High prevalence of undiagnosed coeliac disease in 5280 Italian students screened by antigliadin antibodies
3. The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects
4. Increasing incidence of childhood coeliac disease in Sweden: Results of a national study
5. Down's syndrome is strongly associated with coeliac disease
6. Prevalence of IgA-antigliadin antibodies and IgA-antiendomysium antibodies related to celiac disease in children with Down syndrome
7. Gluten-sensitive enteropathy in patients with insulin-dependent diabetes mellitus
8. Prevalence of coeliac disease in type I diabetes: A multicentre study
9. Coeliac disease in the elderly
10. Coeliac disease
11. Osteoporosis in treated adult coeliac disease
12. Bone mineral affection in asymptomatic adult patients with celiac disease
13. Screening for antibodies against gliadin in patients with osteoporosis
14. Reversal of osteopenia with diet in adult coeliac disease
15. Screening for celiac disease: A prospective study on the value of noninvasive tests
16. Immunological diagnosis of childhood coeliac disease: Comparison between antigliadin, aintireticulin and antiendomysial antibodies
17. Immunologic and absorptive tests in celiac disease: Can they replace intestinal biopsies?
18. Evaluation of the endomysial antibody for celiac disease: Operating properties and associated cost implications for clinical practice
19. Use of immunoglobulin A-antiendomysial antibody to screen for celiac disease in North American children with type 1 diabetes
20. Endomysial antibodies in the diagnosis of celiac disease and the effect of gluten on antibody titers
21. Relationship of endomysial antibodies to jejunal mucosal pathology: Specificity towards both symptomatic and asymptomatic celiacs
22. Primary antibody deficiencies
23. IgA deficiency causes false-negative endomysial antibody results in celiac disease
24. Prevalence and diagnosis of celiac disease in IgA deficient children
25. Coeliac disease in primary care: Case results finding study
26. Coeliac disease in children and adolescents with IDDM: Clinical characteristics and response to gluten-free diet
27. Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies?
28. Screening for celiac disease in apparently healthy blood donors
29. The diagnostic reliability of anti-endomysial antibody in celiac disease: The north Israel experience
30. Comparison of tissue transglutaminase-specific antibody assay with established antibody measurements for coeliac disease
31. Bone remodeling indices and secondary hyperparathyroidism in celiac disease
32. Propeptide of type I procollagen is predictive of posttreatment bone mass gain in adult celiac disease
33. Bone mineral density in coeliac disease
34. Pre- and post-treatment serum levels of cytokines IL-1beta, IL-6, and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia?
35. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis